Ethereum Trader Returns: Buys $5.33 Million After $12 Million Loss
A purchase of $5.33 million within a few hours has reignited the attention of on-chain observers on Ethereum. The protagonist is a trader identified by the address 0xD81a, who after six months of silence has returned to the market by buying 2,165 ETH at an average price of $2,463 each. The return of the Ethereum trader comes at a delicate moment for the market, marked by low volumes and volatility that makes every large move particularly visible to other operators.
Trader 0xD81a has re-entered the Ethereum market after a six-month absence. He purchased 2,165 ETH for $5.33 million, at $2,463 per coin. Previously, he had lost $12 million selling ETH at an average of $2,452. The Ethereum market currently shows low trading volumes and high volatility. The levels to monitor remain $2,463 (purchase price) and $2,452 (previous selling price).
0xD81a had disappeared from the radar after a series of unfortunate trades. His return to the market, after a six-month absence, has not gone unnoticed precisely because it comes accompanied by a significant purchase in a context of reduced trading.
The trader's previous operational cycle had not been positive. In the past, he had sold ETH at an average price of $2,452 after buying it at higher values, accumulating an overall loss estimated at $12 million. This figure makes the decision to return to buying at the price range that cost him so dearly even more significant.
The most recent operation saw 0xD81a buy 2,165 ETH for $5.33 million, at a price of $2,463 per coin. This is a higher level compared to the average selling price of his previous exit, a detail that on-chain analysts have not failed to highlight.
Ethereum is going through a phase of low volumes and scarce price activity, a context that tends to amplify the effect of large orders like the one just executed. In a more liquid market, a purchase of $5.33 million would likely have a marginal impact; under conditions of reduced volumes, however, it can become a signal observed by many.
The current lack of liquidity contributes to making the price of Ethereum more sensitive to isolated movements. It is in this scenario that the purchase by 0xD81a takes on greater weight than it would have in more stable market conditions.
The overall picture remains mixed. Some reference traders, including the analyst known as DonAlt, have indicated that Ethereum shows a relative strength superior to that of Bitcoin, after surpassing resistances between $1,950 and $2,250: a weekly close above $2,300 would be read as confirmation of the movement's strength, with a target indicated around $4,000. At the same time, the market remains divided between bullish readings and bearish positions, an element that makes it even more interesting to observe how other operators will react to the behavior of 0xD81a.
The act of buying at a price higher than his previous loss suggests a possible change of approach, or at least a renewed confidence in Ethereum's trajectory in the short term. It is not an isolated case of speculative behavior: it rather represents an example of how, even after significant losses, traders continue to return to the market when they believe conditions have changed.
Whether it is a technical conviction or a simple attempt to recover previous losses, 0xD81a's move could influence broader sentiment on Ethereum, especially at a time when reduced volumes make every signal louder than usual. Other operators might interpret the purchase as a hint of renewed institutional or semi-institutional confidence in the coin.
From here on, market attention will focus on two precise thresholds: the $2,463 of the recent purchase and the $2,452 of the previous loss sale. How the price reacts around these levels in the coming days could clarify whether 0xD81a's return anticipates a trend change or remains an isolated episode in an uncertain market.
-- Price
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.
You may also like

Controversial Influencer Launches Meme Coin, Hype Fades Quickly

AI is in a Credit Expansion Phase: The Stronger AI Becomes, the More the Federal Reserve Needs to Cut Rates

Chinese Naval Activity Near Taiwan Sets Record for Third Consecutive Month

Hawk Fire Forces Evacuation of 90,000 People Near Reno

Institutional Cryptocurrency Trading Reaches Record 72%: Major Players Smooth Market Volatility

Solana Burn Surges to 87,000 SOL: Does This Change Token Scarcity?

Cryptocurrency Exchange in Russia: Top 3 Services for 2026

Top 20 Cryptocurrencies: New Market Leaders and the Battle for Infrastructure

The US approved high-leverage Bitcoin trading while crypto founders remain legally blocked from raising funds

Central Bank Explains Cryptocurrency Exchange for Russian Securities

Hacker Who Leaked GTA 6 Created a Coin, Soared 20 Times in a Day

CVM Brings Tokenization Agenda to NYSE, Nasdaq, and SEC

Russia Strikes 'Aurora' Distribution Center Twice

Ethereum Accelerates Work on zkEVM Security Ahead of December Deadline

How Big is Iran's Cryptocurrency Market Really? Tracing Billions of Dollars of Iranian Money on the Blockchain

Houthi Claims Drone Attacks on Najran Airport and Aramco

If an Iranian Exchange Goes Bankrupt, Is the User the Owner of the Assets or a Creditor?

Evergrande Founder Sentenced to Life in Prison in China

Why Moderna (MRNA) Stock More Than Doubled: The INTerpath-001 Cancer Vaccine Result, Explained
Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.

Who is Certifying the Crypto Industry Amid the Regulatory 'Vacuum' in the U.S.?

Pressure for Redemptions Grows in $2 Trillion Private Lending Market

Withholdings: How Much the Agricultural Sector Will Contribute Despite Lower Rates

Abelardo De La Espriella Thanks Trump for Assistance After Tragedy

Is Traditional Banking Prepared to Defend Against AI?

Gold Soars to $4,400 as China Continues Its Purchases

Israeli Army Closes Umm al-Khair Village and Restricts Access for Non-Residents

Bitcoin Hesitates, Ethereum Resists – Steady Lads

Hardware Crypto Wallets Have Gained Significant Popularity Among Russians

"Balance Sheet Reduction ≠ Tightening"! Morgan Stanley Explains the Fed's "Asymmetric Balance Sheet Reduction"









